InvestSMART

Biome Australia Limited (ASX: BIO) - Announcements

Current share price for BIO : $0.290 0.005 (1.75%)+

ASX company news and announcements for Biome Australia Limited (BIO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Biome Australia Limited (BIO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Biome Australia Limited (BIO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Biome Australia Limited (BIO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$66 Quarterly Activities & Cashflow Report 29 Jul 2026 8:40AM $0.265 $0.290 risen by 9.43%
$66 International Markets Presentation 27 Jul 2026 9:34AM $0.255 $0.290 risen by 13.73%
$66 Investor Webinar 27 Jul 2026 8:45AM $0.255 $0.290 risen by 13.73%
$66 FY26 Trading Update 1 Jul 2026 8:35AM $0.265 $0.290 risen by 9.43%
$66 Change of Director's Interest Notice 26 Jun 2026 8:43AM $0.245 $0.290 risen by 18.37%
$66 Change of Director's Interest Notice 12 Jun 2026 5:41PM $0.275 $0.290 risen by 5.45%
$66 Ceasing to be a substantial holder 12 Jun 2026 5:34PM $0.275 $0.290 risen by 5.45%
$66 Change of Director's Interest Notice 11 Jun 2026 8:53AM $0.270 $0.290 risen by 7.41%
$66 Change of Director's Interest Notice 4 Jun 2026 8:37AM $0.270 $0.290 risen by 7.41%
$66 Biome Signs Australian Manufacturing Agreement 3 Jun 2026 8:43AM $0.225 $0.290 risen by 28.89%
$66 Biome Investor Presentation June 2026 3 Jun 2026 8:38AM $0.225 $0.290 risen by 28.89%
$66 Investor Webinar 27 May 2026 9:27AM $0.240 $0.290 risen by 20.83%
$66 BMB18 clinical trial expands to dual site 27 May 2026 8:43AM $0.240 $0.290 risen by 20.83%
$66 Probiotical Exclusive Supply Agreement Extended 12 May 2026 8:37AM $0.275 $0.290 risen by 5.45%
$66 Change of Director's Interest Notice 30 Apr 2026 9:23AM $0.300 $0.290 fallen by 3.33%
$66 Change of Director's Interest Notice 29 Apr 2026 9:29AM $0.305 $0.290 fallen by 4.92%
$66 Revised Appendix 4C Quarterly Cash Flow Report 28 Apr 2026 4:45PM $0.305 $0.290 fallen by 4.92%
$66 Quarterly Activities & Cashflow Report 28 Apr 2026 9:14AM $0.325 $0.290 fallen by 10.77%
$66 Patent Application Filed for Probiotic Strain BMB18 27 Apr 2026 9:02AM $0.325 $0.290 fallen by 10.77%
$66 Change of Auditor 10 Apr 2026 5:11PM $0.345 $0.290 fallen by 15.94%
$66 Notification of cessation of securities - BIO 1 Apr 2026 12:00PM $0.340 $0.290 fallen by 14.71%
$66 Secondary Trading Notice 30 Mar 2026 5:53PM $0.315 $0.290 fallen by 7.94%
$66 Application for quotation of securities - BIO 30 Mar 2026 5:46PM $0.315 $0.290 fallen by 7.94%
$66 Secondary Trading Notice 20 Mar 2026 10:01AM $0.345 $0.290 fallen by 15.94%
$66 Application for quotation of securities - BIO 20 Mar 2026 9:57AM $0.350 $0.290 fallen by 17.14%

1 - 25 of 314 results

Page 1 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.